Theratechnologies (NASDAQ:THTX) Stock Price Down 0.6% – Here’s What Happened

Theratechnologies Inc. (NASDAQ:THTX) fell 0.6% during trading on Friday . The company traded as low as $1.69 and last traded at $1.72. 84,056 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 153,814 shares. The stock had previously closed at $1.73.

Theratechnologies Trading Down 0.6 %

The company’s 50 day moving average is $1.55 and its 200 day moving average is $1.40. The company has a market cap of $79.09 million, a PE ratio of -17.20 and a beta of 1.30.

Institutional Investors Weigh In On Theratechnologies

A hedge fund recently raised its stake in Theratechnologies stock. National Bank of Canada FI lifted its holdings in Theratechnologies Inc. (NASDAQ:THTX) by 29.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 186,815 shares of the company’s stock after purchasing an additional 42,435 shares during the period. National Bank of Canada FI owned about 0.41% of Theratechnologies worth $232,000 at the end of the most recent quarter.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.